PURPOSE: Although most childhood cancer survivors see a primary care provider (PCP), little is known about these encounters. We explored themes related to survivors' (1) experiences with primary care, (2) communication with their PCPs about their cancer, and (3) their knowledge and impressions about follow-up care, including their interest in a survivor care plan (SCP). METHODS: From April to July 2012, we conducted in-depth, semi-structured telephone interviews with 53 adult survivors recruited from the Utah Cancer Surveillance, Epidemiology, and End Results (SEER) Registry. Participants were randomly selected from sex, age, and rural/urban strata and were younger than 21 years at the time of diagnosis. Participants were asked if they had a PCP and whether they discussed their cancer history with their provider and their interest in a SCP. Interviews were recorded, transcribed, and content-analyzed. RESULTS: The average age at interview was 39.1 years (SD = 11.2). Most survivors had a current PCP (83.0 %). Almost half were not worried about their health despite having had cancer. Detailed discussions about cancer history with PCPs were generally rare. Few survivors had a follow-up care plan, but over half thought a SCP could empower their medical decision making. However, one-third of the survivors were skeptical about the usefulness of a SCP and some were worried about health-care costs. CONCLUSIONS: Childhood cancer survivors need better care coordination. Of concern is that many do not discuss their cancer history with their current PCPs and most have no SCP.
PURPOSE: Although most childhoodcancer survivors see a primary care provider (PCP), little is known about these encounters. We explored themes related to survivors' (1) experiences with primary care, (2) communication with their PCPs about their cancer, and (3) their knowledge and impressions about follow-up care, including their interest in a survivor care plan (SCP). METHODS: From April to July 2012, we conducted in-depth, semi-structured telephone interviews with 53 adult survivors recruited from the Utah Cancer Surveillance, Epidemiology, and End Results (SEER) Registry. Participants were randomly selected from sex, age, and rural/urban strata and were younger than 21 years at the time of diagnosis. Participants were asked if they had a PCP and whether they discussed their cancer history with their provider and their interest in a SCP. Interviews were recorded, transcribed, and content-analyzed. RESULTS: The average age at interview was 39.1 years (SD = 11.2). Most survivors had a current PCP (83.0 %). Almost half were not worried about their health despite having had cancer. Detailed discussions about cancer history with PCPs were generally rare. Few survivors had a follow-up care plan, but over half thought a SCP could empower their medical decision making. However, one-third of the survivors were skeptical about the usefulness of a SCP and some were worried about health-care costs. CONCLUSIONS:Childhoodcancer survivors need better care coordination. Of concern is that many do not discuss their cancer history with their current PCPs and most have no SCP.
Authors: Paul Craig Nathan; Christopher Keller Daugherty; Kristen Elizabeth Wroblewski; Mackenzie Louise Kigin; Tom Vernon Stewart; Fay Jarmila Hlubocky; Eva Grunfeld; Marie Elisabeth Del Giudice; Leigh-Anne Evelyn Ward; James Mahlon Galliher; Kevin Charles Oeffinger; Tara Olive Henderson Journal: J Cancer Surviv Date: 2013-03-08 Impact factor: 4.442
Authors: Winson Y Cheung; Bridget A Neville; Danielle B Cameron; E Francis Cook; Craig C Earle Journal: J Clin Oncol Date: 2009-03-30 Impact factor: 44.544
Authors: Nina S Kadan-Lottick; Leslie L Robison; James G Gurney; Joseph P Neglia; Yutaka Yasui; Robert Hayashi; Melissa Hudson; Mark Greenberg; Ann C Mertens Journal: JAMA Date: 2002-04-10 Impact factor: 157.335
Authors: Paul C Nathan; Mark L Greenberg; Kirsten K Ness; Melissa M Hudson; Ann C Mertens; Martin C Mahoney; James G Gurney; Sarah S Donaldson; Wendy M Leisenring; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2008-09-20 Impact factor: 50.717
Authors: Emily S Tonorezos; Melissa M Hudson; Angela B Edgar; Leontien C Kremer; Charles A Sklar; W Hamish B Wallace; Kevin C Oeffinger Journal: Lancet Diabetes Endocrinol Date: 2015-04-12 Impact factor: 32.069
Authors: Gisela Michel; Renée L Mulder; Helena J H van der Pal; Roderick Skinner; Edit Bárdi; Morven C Brown; Janine Vetsch; Eva Frey; Rachael Windsor; Leontien C M Kremer; Gill Levitt Journal: J Cancer Surviv Date: 2019-08-08 Impact factor: 4.442
Authors: Alex W K Wong; Ting-Ting Chang; Katrina Christopher; Stephen C L Lau; Lynda K Beaupin; Brad Love; Kim L Lipsey; Michael Feuerstein Journal: J Cancer Surviv Date: 2017-03-29 Impact factor: 4.442
Authors: Christina Signorelli; Claire E Wakefield; Joanna E Fardell; Tali Foreman; Karen A Johnston; Jon Emery; Elysia Thornton-Benko; Afaf Girgis; Hanne C Lie; Richard J Cohn Journal: Oncologist Date: 2018-08-31
Authors: Lisa K Sharp; Priscilla Carvalho; Matthew Southward; Mary Lou Schmidt; Leslie N Jabine; Melinda R Stolley; Ben S Gerber Journal: J Adolesc Young Adult Oncol Date: 2014-09-01 Impact factor: 2.223
Authors: Alexandra M Psihogios; Lisa A Schwartz; Janet A Deatrick; Elizabeth S Ver Hoeve; Lindsay M Anderson; Elicia C Wartman; Dava Szalda Journal: J Cancer Surviv Date: 2019-07-04 Impact factor: 4.442
Authors: Morgan M Millar; Anita Y Kinney; Nicola J Camp; Lisa A Cannon-Albright; Mia Hashibe; David F Penson; Anne C Kirchhoff; Deborah W Neklason; Alicia W Gilsenan; Gretchen S Dieck; Antoinette M Stroup; Sandra L Edwards; Carrie Bateman; Marjorie E Carter; Carol Sweeney Journal: Am J Epidemiol Date: 2019-05-01 Impact factor: 4.897
Authors: E Anne Lown; Farya Phillips; Lisa A Schwartz; Abby R Rosenberg; Barbara Jones Journal: Pediatr Blood Cancer Date: 2015-12 Impact factor: 3.167